PITTSBURGH--(BUSINESS WIRE)--Pittsburgh based Lipella Pharmaceuticals Inc. today announced newly published results of a multi-site, double-blind, placebo-controlled clinical trial comparing the ...
Hosted on MSN
The FDA approved an updated LP.8.1 COVID vaccine for adults 65 and older and high-risk people ages 5 through 64
Adults 65 and older, along with people ages 5 through 64 who face elevated risk from COVID-19, now have access to an updated vaccine matched to a strain that has been circulating widely. The FDA ...
PITTSBURGH, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella" or the "Company"), a clinical-stage biotechnology company focused on developing innovative ...
Lipella Pharmaceuticals Inc, a clinical-stage biotechnology company focused on developing innovative therapies by reformulating active agents in existing generic drugs, announced that the US Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results